risks of glp 1 medications GLP-1 Medications: Is Ozempic the Best Option for You? Why do patients stop GLP-1

SAN DIEGO(March 10, 2025)Glucagon-like peptide-1 receptor agonists (GLP-1 agonists), such as semaglutide (e.g., Ozempic), have helped improve the management of type 2 diabetes and obesity

Roche reported positive Phase II topline data showing that its once-weekly dual glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonist CT-388 achieved substantial, sustained, and dose-dependent weight loss through 48 weeks

Reduced risk of side effects

All research peptides arrive in a dry lyophilized powder

Daily Digestive Wellness: Features organic Ginger and Moringa leaves, traditionally enjoyed to support digestion and overall wellness

Up to 65% improvement in feelings of fullness